Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency ...

Global pharma major Lupin Limited on Friday announced that it has received ... infection in adult patients and in pediatric ...

An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, ...

Lupin receives US FDA tentative approval for raltegravir tablets, USP: Our Bureau, Mumbai Friday, November 8, 2024, 17:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...

Look out for ITI Ltd., Lupin Ltd., Brigade Enterprises Ltd., Tata Motors Ltd. and State Bank of India in trade on Friday.

North America Q2 sales were Rs 1,971.1 crore, up 5.6 percent compared to Rs 1,866.6 crore, accounting for 36 percent of Lupin ...

Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its research report ...

NSE's Nifty50 tumbled 324.40 points, or 1.36 per cent ... On the daily time frame, Lupin has broken down from a descending triangle pattern, signaling a negative trend. Sellers appear increasingly ...

EBITDA also fell by 9% to Rs 271.5 crore from Rs 298.3 crore, and margins narrowed by 40 basis points to 5.6% from 6%. The company reported a 41.2% drop in consolidated profit for Q2, which fell to Rs ...

However, buying interest returned, lifting the Sensex up by 88 points to 79,629.58 and the Nifty up by 15 points to 24,214.40 ...

Sandip Sabharwal, asksandipsabharwal.com discusses key stock picks and sector outlooks, offering insights on Asian Paints' weak quarter, the recovery potential in the auto sector, and opportunities in ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...